Rodrigues CF, Silva S, Henriques M. Candida glabrata: a review of its features and resistance. Eur J Clin Microbiol Infect Dis 2014;33:673-88.
Brunke S, Hube B. Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell Microbiol 2013;15:701-8.
Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect 2014;20 Suppl 6:5-10.
Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, et al. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med 2015;41:285-95.
Gupta A, Gupta A, Varma A. Candida glabrata candidemia: An emerging threat in critically ill patients. Ind J of Crit Care Med 2015;19:151-154.
Colombo RE, Vazquez J. Echinocandins for primary therapy of candidemia: Time for a Paradigm shift? Curr Fungal Infect Rep 2015;9:15-22.
Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol 2012;50:1199-203.
Arendrup MC, Perlin DS. Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis 2014;27:484-92.
Shields RK, Nguyen MH, Press EG, Updike CL, Clancy CJ. Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure. Antimicrob Agents Chemother 2013;57:3528-35.